SYDNEY, Feb. 24, 2026 (GLOBE NEWSWIRE) — EMVision Medical Devices Limited (ASX:EMV), based in Sydney, Australia, focused on delivering novel diagnostic devices for stroke and traumatic brain injury patients, today announced that Adam Millhouse, Head of Corporate Strategy and Development, will present live at Australia Investor Day hosted by VirtualInvestorConferences.com and OTC Markets Group, on February 26th, 2026






